980 related articles for article (PubMed ID: 22019747)
1. Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).
El-Mesallamy HO; Hamdy NM; Salman TM; Mahmoud S
Minerva Endocrinol; 2011 Sep; 36(3):163-70. PubMed ID: 22019747
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin and sE-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease.
El-Mesallamy HO; Hamdy NM; Salman TM; Ibrahim SM
Angiology; 2012 Feb; 63(2):96-102. PubMed ID: 21602254
[TBL] [Abstract][Full Text] [Related]
3. Plasma adiponectin and E-selectin concentrations in patients with coronary heart disease and newly diagnosed disturbances of glucose metabolism.
Kowalska I; Straczkowski M; Nikołajuk A; Kinalska I; Górska M; Prokop J; Bachórzewska-Gajewska H; Musiał W
Adv Med Sci; 2006; 51():94-7. PubMed ID: 17357284
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin and pro-inflammatory cytokines in obese diabetic boys.
El-Mesallamy HO; Hamdy NM; Ibrahim SM
Indian Pediatr; 2011 Oct; 48(10):815-6. PubMed ID: 22080689
[TBL] [Abstract][Full Text] [Related]
5. Relation of inflammatory chemokines to insulin resistance and hypoadiponectinemia in coronary artery disease patients.
Tretjakovs P; Jurka A; Bormane I; Mackevics V; Mikelsone I; Balode L; Reihmane D; Stukena I; Bahs G; Aivars JI; Pirags V
Eur J Intern Med; 2009 Nov; 20(7):712-7. PubMed ID: 19818293
[TBL] [Abstract][Full Text] [Related]
6. Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians.
Nayak BS; Ramsingh D; Gooding S; Legall G; Bissram S; Mohammed A; Raychaudhuri A; Sahadeo B; Pandohie V; Figaro K
Prim Care Diabetes; 2010 Oct; 4(3):187-92. PubMed ID: 20580627
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance--the Chennai Urban Rural Epidemiology Study (CURES).
Deepa R; Velmurugan K; Arvind K; Sivaram P; Sientay C; Uday S; Mohan V
Metabolism; 2006 Sep; 55(9):1232-8. PubMed ID: 16919544
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
[TBL] [Abstract][Full Text] [Related]
9. The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.
Daniele G; Guardado Mendoza R; Winnier D; Fiorentino TV; Pengou Z; Cornell J; Andreozzi F; Jenkinson C; Cersosimo E; Federici M; Tripathy D; Folli F
Acta Diabetol; 2014 Feb; 51(1):123-31. PubMed ID: 24370923
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.
Kim CS; Park HS; Kawada T; Kim JH; Lim D; Hubbard NE; Kwon BS; Erickson KL; Yu R
Int J Obes (Lond); 2006 Sep; 30(9):1347-55. PubMed ID: 16534530
[TBL] [Abstract][Full Text] [Related]
11. Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.
Chacón MR; Fernández-Real JM; Richart C; Megía A; Gómez JM; Miranda M; Caubet E; Pastor R; Masdevall C; Vilarrasa N; Ricard W; Vendrell J
Obesity (Silver Spring); 2007 Mar; 15(3):664-72. PubMed ID: 17372317
[TBL] [Abstract][Full Text] [Related]
12. The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus.
Kadoglou NP; Iliadis F; Angelopoulou N; Perrea D; Ampatzidis G; Liapis CD; Alevizos M
Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):837-43. PubMed ID: 18043308
[TBL] [Abstract][Full Text] [Related]
13. Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism.
Blüher M; Fasshauer M; Tönjes A; Kratzsch J; Schön MR; Paschke R
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):534-7. PubMed ID: 16235156
[TBL] [Abstract][Full Text] [Related]
14. [Plasma level of adiponectin in coronary heart disease patients combined with abnormal glucose metabolism].
Xia K; Guo L; Zhao Z; Md Sayed AS; Li F; Yang T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 37(2):179-84. PubMed ID: 22561436
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress and inflammatory markers in relation to circulating levels of adiponectin.
Gustafsson S; Lind L; Söderberg S; Zilmer M; Hulthe J; Ingelsson E
Obesity (Silver Spring); 2013 Jul; 21(7):1467-73. PubMed ID: 23585283
[TBL] [Abstract][Full Text] [Related]
16. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
17. Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support.
White M; Ducharme A; Ibrahim R; Whittom L; Lavoie J; Guertin MC; Racine N; He Y; Yao G; Rouleau JL; Schiffrin EL; Touyz RM
Clin Sci (Lond); 2006 Apr; 110(4):483-9. PubMed ID: 16402915
[TBL] [Abstract][Full Text] [Related]
18. Which obesity index best explains the link between adipokines, coronary heart disease risk and metabolic abnormalities in type 2 diabetes mellitus?
Mojiminiyi OA; Al Mulla F; Abdella NA
Med Princ Pract; 2009; 18(2):123-9. PubMed ID: 19204431
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
20. Plasma leptin concentration in patients with Type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance.
Abdella NA; Mojiminiyi OA; Moussa MA; Zaki M; Al Mohammedi H; Al Ozairi ES; Al Jebely S
Diabet Med; 2005 Mar; 22(3):278-85. PubMed ID: 15717875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
